SOLICITATION NOTICE
68 -- Purchase EMD Chemical ProteoExtract Phosphopeptide Enrichment Kits
- Notice Date
- 8/15/2012
- Notice Type
- Presolicitation
- NAICS
- 325199
— All Other Basic Organic Chemical Manufacturing
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 2012-Q-15075
- Archive Date
- 9/14/2012
- Point of Contact
- Vallerie M Redd, Phone: 770-488-2845
- E-Mail Address
-
gfj3@cdc.gov
(gfj3@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- The Center for Disease Control and Prevention (CDC), National Center for Environmental Health (NCEH), Division of Laboratory Science (DLS), intends to award a sole source purchase order to EMD Chemicals, 290 Concord Road, Billerica, MA 01821, for the purchase of EMD Chemical ProteoExtract Phosphopeptide Enrichment Kits. The statutory authority for this sole source acquisition is 10 U.S.C 2304(c)(1) in accordance with FAR Part 6.302-1- only one responsible source and no other supplies or services will satisfy the agency requirement. The NAICS code for this procurement is 325199, All Other Basic Organic Chemical Manufacturing. The purpose of this acquisition is to purchase EMD Chemical ProteoExtract Phosphopeptide Enrichment Kits from EMD Chemicals. During development and optimization of the method to assess exposure to nerve agents by analysis of metabolites in urine by liquid chromatography and tandem mass spectrometery, several other alternative phosphopeptide enrichment products from other vendors were compared to those from EMD Chemicals. The EMD Chemicals phosphopeptide enrichment kit is the only product with the required throughput, recovery, and specificity for this method. This method is being validated using this kit, and this kit is required to run this established method. Thus, EMD Chemicals, the manufacturer of these enrichment kits, is the only company that can be used. As a result of this synopsis, no competitive solicitation will be posted on FedBizOpps. We will issue only one solicitation to EMD Chemicals. However, firms that believe they can meet these requirements are encouraged to identify themselves and give written notice by providing a capability statement to the Contracting Officer by August 30, 2012. The Contracting Officer will not respond to verbal request. All requests must be in writing. A determination by the Government not to compete this proposed action will be based on responses to this notice and are solely within the discretion of the Contracting Officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Inquiries shall be sent to Vallerie Redd by email at gfj3@cdc.gov and reference solicitation number 2012-Q-15075 on the subject line.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2012-Q-15075/listing.html)
- Place of Performance
- Address: CDC's Facility, Atlanta, Georgia, United States
- Record
- SN02841180-W 20120817/120816001039-1b27fe28e5dd37d0da2243e01f39b033 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |